The annual challenge of the global health community is progressing innovative products (vaccines, antiviral drugs, immunomodulators) for the control of infections of significant disease burden in a timely manner at an optimum cost. hVIVO and its associated laboratory services provides a single, centralised testing ability to reduce time and costs and provide specialised scientific design services throughout all phases of your development program.
hVIVO Labs is a highly specialised virology and immunology laboratory offering a suite of services to support pre-clinical and clinical respiratory drug and vaccine discovery and development.
Reliable laboratory analysis underpinned by scientific expertise is essential when processing and analysing clinical samples. Robust quality processes support our team of scientists in the delivery of submission ready data.
Clinical Laboratory Services
End to end lab support services, from clinical trial and field study sampling kit provision with sample stabilisation to data management and reporting
Quality management system supporting our project teams to deliver the highest standard of clinical data
Projects supported by a team of over 40 lab scientists working in a GCLP accredited lab, providing scientific oversight, project and data management, sample logistics and assays validated to FDA, EMA and ICH guidelines
Bespoke Assay Development
Ability to provide bespoke assays when needed to optimise study outcomes and provide exploratory endpoints
Extensive experience in assay development and validation to EMA, FDA and the ICH guidelines providing sensitive, clinically robust assays
Consolidating your biomarker analysis to a single source lab will reduce time and costs throughout client development programs
We offer a wide range of assays including:
real-time quantitative RT-PCR
rapid qPCR for triggered dosing challenges
humoral & cell-mediated immune responses
Currently developing biomarker assays for Asthma and COPD models